TipHub

₹35

▼ -1.19 -3.29%

29 Jul 2026

BSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-06-25

ANG Lifesciences India Limited (540694)

Volume: 1,641Avg Vol 1W: 6,094Avg Vol 1M: 7,05352W Range:₹17.63₹49.69
BSE www.anglifesciences.com AI Report
Key Ratios
Checked 6h ago
Market Cap₹49 Cr
Current Price₹35
Previous Close₹36.19
High / Low (52w)₹49.69 / ₹17.63
Volume1,641
Avg Vol (1W)6,094
Avg Vol (1M)7,053
Stock P/E—
Book Value₹40.5
Dividend Yield0%
ROE-20.96%
ROA-5.31%
Revenue (TTM)—
Revenue Growth—
Profit Margin-11.94%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0.92
Debt / Equity1.11
50 DMA₹32.3
200 DMA₹28.43
Day change-3.29%
SurveillanceESM · ESM 1
Price Chart
₹35▲ 16.43% · 1Y
₹43₹182.6L
2025-08-04
2026-07-29

20-day avg volume: 6K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 25% YoY.
  • Stock trades below its book value.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹18 Cr₹33 Cr₹25 Cr₹17 Cr₹25 Cr₹26 Cr₹19 Cr₹24 Cr
EBITDA₹-2 Cr₹1 Cr₹-4 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹-4 Cr₹1 Cr
Net Profit₹-3 Cr₹-2 Cr₹-5 Cr₹-2 Cr₹-2 Cr₹-3 Cr₹-5 Cr₹-1 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹32 Cr₹24 Cr₹18 Cr₹95 Cr₹25 Cr₹26 Cr₹18 Cr₹23 Cr
EBITDA₹1 Cr₹-4 Cr₹-1 Cr₹-7 Cr₹1 Cr₹1 Cr₹-3 Cr₹3 Cr
Net Profit₹-1 Cr₹-5 Cr₹-2 Cr₹-12 Cr₹-1 Cr₹-1 Cr₹-4 Cr₹1 Cr
EPS———-9.42————
Balance Sheet
MetricMar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹291 Cr₹278 Cr₹242 Cr₹230 Cr
Total Liabilities₹207 Cr₹191 Cr₹166 Cr₹166 Cr
Equity₹84 Cr₹86 Cr₹76 Cr₹64 Cr
Total Debt————
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025
Operating₹25 Cr₹30 Cr₹4 Cr₹4 Cr
Investing₹-44 Cr₹-9 Cr₹20 Cr₹-2 Cr
Financing₹20 Cr₹-17 Cr₹-10 Cr₹2 Cr
Free Cash Flow₹25 Cr₹30 Cr₹4 Cr₹4 Cr
Shareholding
Promoter 70.6% Institutions 0% Public 29.4%
Efficiency & Working Capital
ROCE-3.8%
Interest Coverage-0.7
Dividend Payout—
Debtor Days262 d
Inventory Days213 d
Payable Days260 d
Cash Conversion Cycle215 d
Working Capital Days474 d
Shareholding Details

As of 2026-03-31

Promoter70.6%
FII0%
DII0%
Institutions0%
Public29.4%
Promoter Pledge44.9%
No. of Shareholders5,952
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters70.6%70.6%70.6%70.6%70.6%70.6%70.6%70.6%70.6%70.6%70.6%70.6%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public29.4%29.4%29.4%29.4%29.4%29.4%29.4%29.4%29.4%29.4%29.4%29.4%
Promoter Pledge44.9%44.9%44.9%44.9%44.9%44.9%44.9%44.9%44.9%44.9%44.9%44.9%
No. of Shareholders7,3057,0556,9186,8686,6316,4686,5176,5086,4006,2736,0845,952
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Rajesh GuptaShareholding of Promoter and Promoter Group70.4%91,94,537
Saruchi GuptaShareholding of Promoter and Promoter Group0.2%25,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Rajesh Gupta41,37,50045%2026-03-31
Board of Directors
NameDesignationYear
Rajesh GuptaExecutive Director & MD2025
Saruchi GuptaExecutive Director / Whole Time Director / CFO2025
Rohit MittalNon Executive Director2025
Harvinder Singh DhamiIndependent Non Exe. Director2025
Sukhpal SinghIndependent Non Exe. Director2025
ChetnaIndependent Non Exe. Director2025
Harshita AggarwalCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
Outside India₹5 Cr5.6%
Within India₹85 Cr94.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10141313
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025900191037
202540017021
2025200104
Company Information
Incorporated2006
AuditorKhurana Sharma & Co
Investor Email[email protected]
🌐 www.anglifesciences.com ↗

📍 Darbara Complex SCO 113 I Flr, Dist. Shopping Centre B Block, Amritsar, Punjab, 143001

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Jigar Cables LimitedCaptain Technocast LimitedGlobalspace Technologies Ltd.Chothani Foods LimitedSmruthi Organics LimitedShish Industries LimitedKCD Industries India LimitedDixon TechnologiesBharat Road NetworkDishman Carbogen AmcisLasa SupergenericsPro CLB Global LimitedAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search